Convalescent plasma reduces mortality by 10% in COVID-19 patients on artificial respiratory assistance: Clinical trial

In a study published in the New England Journal of Medicine, clinicians and researchers from the CHU of Liège and the University of Liège show that the administration of plasma taken from convalescent donors after infection with SARS-CoV-2 to patients suffering from acute respiratory distress syndrome requiring artificial mechanical ventilation significantly reduced mortality (10%).